FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1994933863> ?p ?o ?g. }

• W1994933863 endingPage "63" @default.
• W1994933863 startingPage "53" @default.
• W1994933863 abstract "ObjectiveHistone deacetylase inhibitors mediate a potent growth-inhibitory effect in cancer cells through induction of cell-cycle arrest and apoptosis. Moreover, these agents significantly induce transcriptional activation of nuclear factor κB, as well as p21 regulated by protein kinase C, and are thought to negatively influence the ability of histone deacetylase inhibitor to effectively mediate apoptosis. This study aimed to evaluate the effect of calphostin C (a protein kinase C inhibitor) on trichostatin A (a histone deacetylase inhibitor)–mediated upregulation of nuclear factor κB and p21 promotor transcriptional activity, as well as induction of apoptosis in lung and esophageal cancer cells.MethodsCultured lung and esophageal cancer cells were treated with calphostin C and trichostatin A. Nuclear factor κB transcriptional activity was quantitated by using the nuclear factor κB–luciferase assay. Transcription of p21 gene and p21 protein levels was evaluated by using the p21 promoter–luciferase assay and the p21 enzyme-linked immunoassay, respectively. Apoptosis was evaluated by using the terminal deoxynucleotidyl transferase–mediated dUTP nick end labeling–based ApoBrdU assay. Levels of expression of nuclear factor κB–dependent antiapoptotic and proapoptotic proteins were evaluated by means of Western blotting.ResultsExposure of lung or esophageal cancer cells to trichostatin A resulted in a dose- and cell-dependent 2-fold to greater than 20-fold increase of nuclear factor κB and p21 transcriptional activity. Treatment with trichostatin A and calphostin C led to a 50% to 90% decrease of trichostatin A– mediated upregulation of nuclear factor κB and p21 activation. Inhibition of nuclear factor κB activity resulted in significant reduction (30% to >99%) of trichostatin A– mediated activation of not only nuclear factor κB transcription but also p21 promotor activity. Importantly, 90% to 96% of thoracic cancer cells under-went apoptosis after exposure to the combination of trichostatin A plus calphostin C.ConclusionInhibition of protein kinase C abrogates trichostatin A–mediated upregulation of nuclear factor κB transcriptional activity and p21 expression that is associated with profound induction of apoptosis in lung or esophageal cancer cells. Protein kinase C might be a novel target for enhancing the efficacy of histone deacetylase inhibitor in cancer therapy. Histone deacetylase inhibitors mediate a potent growth-inhibitory effect in cancer cells through induction of cell-cycle arrest and apoptosis. Moreover, these agents significantly induce transcriptional activation of nuclear factor κB, as well as p21 regulated by protein kinase C, and are thought to negatively influence the ability of histone deacetylase inhibitor to effectively mediate apoptosis. This study aimed to evaluate the effect of calphostin C (a protein kinase C inhibitor) on trichostatin A (a histone deacetylase inhibitor)–mediated upregulation of nuclear factor κB and p21 promotor transcriptional activity, as well as induction of apoptosis in lung and esophageal cancer cells. Cultured lung and esophageal cancer cells were treated with calphostin C and trichostatin A. Nuclear factor κB transcriptional activity was quantitated by using the nuclear factor κB–luciferase assay. Transcription of p21 gene and p21 protein levels was evaluated by using the p21 promoter–luciferase assay and the p21 enzyme-linked immunoassay, respectively. Apoptosis was evaluated by using the terminal deoxynucleotidyl transferase–mediated dUTP nick end labeling–based ApoBrdU assay. Levels of expression of nuclear factor κB–dependent antiapoptotic and proapoptotic proteins were evaluated by means of Western blotting. Exposure of lung or esophageal cancer cells to trichostatin A resulted in a dose- and cell-dependent 2-fold to greater than 20-fold increase of nuclear factor κB and p21 transcriptional activity. Treatment with trichostatin A and calphostin C led to a 50% to 90% decrease of trichostatin A– mediated upregulation of nuclear factor κB and p21 activation. Inhibition of nuclear factor κB activity resulted in significant reduction (30% to >99%) of trichostatin A– mediated activation of not only nuclear factor κB transcription but also p21 promotor activity. Importantly, 90% to 96% of thoracic cancer cells under-went apoptosis after exposure to the combination of trichostatin A plus calphostin C. Inhibition of protein kinase C abrogates trichostatin A–mediated upregulation of nuclear factor κB transcriptional activity and p21 expression that is associated with profound induction of apoptosis in lung or esophageal cancer cells. Protein kinase C might be a novel target for enhancing the efficacy of histone deacetylase inhibitor in cancer therapy." @default.
• W1994933863 created "2016-06-24" @default.
• W1994933863 creator A5005067201 @default.
• W1994933863 creator A5033824271 @default.
• W1994933863 creator A5043202971 @default.
• W1994933863 creator A5067182967 @default.
• W1994933863 creator A5087585435 @default.
• W1994933863 creator A5091311134 @default.
• W1994933863 date "2005-01-01" @default.
• W1994933863 modified "2023-10-12" @default.
• W1994933863 title "Induction of apoptosis of lung and esophageal cancer cells treated with the combination of histone deacetylase inhibitor (trichostatin A) and protein kinase C inhibitor (calphostin C)" @default.
• W1994933863 cites W1983820813 @default.
• W1994933863 cites W1983829192 @default.
• W1994933863 cites W1994731089 @default.
• W1994933863 cites W2015519364 @default.
• W1994933863 cites W2028958094 @default.
• W1994933863 cites W2029524330 @default.
• W1994933863 cites W2031397616 @default.
• W1994933863 cites W2072259101 @default.
• W1994933863 cites W2072963392 @default.
• W1994933863 cites W2098617365 @default.
• W1994933863 cites W2108230631 @default.
• W1994933863 cites W2109869748 @default.
• W1994933863 cites W2123687793 @default.
• W1994933863 cites W2161444897 @default.
• W1994933863 cites W2318410985 @default.
• W1994933863 doi "https://doi.org/10.1016/j.jtcvs.2004.07.051" @default.
• W1994933863 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15632825" @default.
• W1994933863 hasPublicationYear "2005" @default.
• W1994933863 type Work @default.
• W1994933863 sameAs 1994933863 @default.
• W1994933863 citedByCount "18" @default.
• W1994933863 countsByYear W19949338632016 @default.
• W1994933863 countsByYear W19949338632020 @default.
• W1994933863 countsByYear W19949338632022 @default.
• W1994933863 crossrefType "journal-article" @default.
• W1994933863 hasAuthorship W1994933863A5005067201 @default.
• W1994933863 hasAuthorship W1994933863A5033824271 @default.
• W1994933863 hasAuthorship W1994933863A5043202971 @default.
• W1994933863 hasAuthorship W1994933863A5067182967 @default.
• W1994933863 hasAuthorship W1994933863A5087585435 @default.
• W1994933863 hasAuthorship W1994933863A5091311134 @default.
• W1994933863 hasBestOaLocation W19949338631 @default.
• W1994933863 hasConcept C104317684 @default.
• W1994933863 hasConcept C153911025 @default.
• W1994933863 hasConcept C184235292 @default.
• W1994933863 hasConcept C27253355 @default.
• W1994933863 hasConcept C2776202225 @default.
• W1994933863 hasConcept C2777865847 @default.
• W1994933863 hasConcept C2778305200 @default.
• W1994933863 hasConcept C2780245509 @default.
• W1994933863 hasConcept C502942594 @default.
• W1994933863 hasConcept C55493867 @default.
• W1994933863 hasConcept C64927066 @default.
• W1994933863 hasConcept C71924100 @default.
• W1994933863 hasConcept C86803240 @default.
• W1994933863 hasConcept C95444343 @default.
• W1994933863 hasConcept C97029542 @default.
• W1994933863 hasConceptScore W1994933863C104317684 @default.
• W1994933863 hasConceptScore W1994933863C153911025 @default.
• W1994933863 hasConceptScore W1994933863C184235292 @default.
• W1994933863 hasConceptScore W1994933863C27253355 @default.
• W1994933863 hasConceptScore W1994933863C2776202225 @default.
• W1994933863 hasConceptScore W1994933863C2777865847 @default.
• W1994933863 hasConceptScore W1994933863C2778305200 @default.
• W1994933863 hasConceptScore W1994933863C2780245509 @default.
• W1994933863 hasConceptScore W1994933863C502942594 @default.
• W1994933863 hasConceptScore W1994933863C55493867 @default.
• W1994933863 hasConceptScore W1994933863C64927066 @default.
• W1994933863 hasConceptScore W1994933863C71924100 @default.
• W1994933863 hasConceptScore W1994933863C86803240 @default.
• W1994933863 hasConceptScore W1994933863C95444343 @default.
• W1994933863 hasConceptScore W1994933863C97029542 @default.
• W1994933863 hasIssue "1" @default.
• W1994933863 hasLocation W19949338631 @default.
• W1994933863 hasLocation W19949338632 @default.
• W1994933863 hasOpenAccess W1994933863 @default.
• W1994933863 hasPrimaryLocation W19949338631 @default.
• W1994933863 hasRelatedWork W124145031 @default.
• W1994933863 hasRelatedWork W2003519583 @default.
• W1994933863 hasRelatedWork W2074781740 @default.
• W1994933863 hasRelatedWork W2083299719 @default.
• W1994933863 hasRelatedWork W2098012859 @default.
• W1994933863 hasRelatedWork W2114166108 @default.
• W1994933863 hasRelatedWork W2153193637 @default.
• W1994933863 hasRelatedWork W2154986110 @default.
• W1994933863 hasRelatedWork W2325580371 @default.
• W1994933863 hasRelatedWork W3030950996 @default.
• W1994933863 hasVolume "129" @default.
• W1994933863 isParatext "false" @default.
• W1994933863 isRetracted "false" @default.
• W1994933863 magId "1994933863" @default.
• W1994933863 workType "article" @default.